Carlsmed, Inc. Common Stock CARL Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $56.44M+74.9% | $50.51M+85.9% | $44.75M— | $38.27M— | $32.27M— | ||
| $13.61M+65.0% | $12.47M+75.2% | $11.3M— | $9.94M— | $8.25M— | ||
| $42.83M+78.3% | $38.04M+89.7% | $33.46M— | $28.33M— | $24.02M— | ||
| 75.9%+1.4pp | 75.3%+1.5pp | 74.8%— | 74%— | 74.4%— | ||
| $19.05M+34.2% | $17.02M+19.0% | $14.77M— | $14.36M— | $14.2M— | ||
| $38.59M+56.8% | $35.03M+63.1% | $30.6M— | $27.61M— | $24.61M— | ||
| $19.33M+98.8% | $16.57M+97.4% | $14.04M— | $11.05M— | $9.72M— | ||
| $76.96M+58.6% | $68.61M+55.3% | $59.41M— | $53.02M— | $48.53M— | ||
| $76.96M+58.6% | $68.61M+55.3% | $59.41M— | $53.02M— | $48.53M— | ||
| -$34.13M-39.2% | -$30.57M-26.7% | -$25.95M— | -$24.7M— | -$24.51M— | ||
| -60.5%+15.5pp | -60.5%+28.3pp | -58%— | -64.5%— | -76%— | ||
| $1.38M-5.3% | $1.43M+8.3% | $1.48M— | $1.5M— | $1.46M— | ||
| $3.21M+99.1% | $2.7M+103% | $2.08M— | $1.52M— | $1.61M— | ||
| $1.53M+5,767% | $940K+796% | $212K— | -$333K— | -$27K— | ||
| -$32.6M-32.9% | -$29.63M-22.2% | -$25.74M— | -$25.03M— | -$24.54M— | ||
| -57.8%+18.3pp | -58.7%+30.6pp | -57.5%— | -65.4%— | -76%— | ||
| —— | $584K— | —— | —— | —— | ||
| —— | —— | -$4.48— | -$6.14— | -$6.22— | ||
| —— | —— | -$4.48— | -$6.14— | -$6.22— | ||
| 66.7M+304% | 44.2M— | 34M— | 17M— | 16.5M— | ||
| 66.7M+304% | 44.2M— | 34M— | 17M— | 16.5M— | ||
| -$32.6M-32.9% | -$29.63M-22.2% | -$25.74M— | -$25.03M— | -$24.54M— | ||
| $1.53M+5,767% | $940K+796% | $212K— | -$333K— | -$27K— | ||
| -$34.13M-39.2% | -$30.57M-26.7% | -$25.95M— | -$24.7M— | -$24.51M— | ||
| -$33.79M— | -$30.29M— | -$25.73M— | -$24.52M— | —— | ||
| -$33.79M— | -$30.29M— | -$25.73M— | -$24.52M— | —— | ||
| -59.9%— | -60%— | -57.5%— | -64.1%— | —— | ||
| -$34.13M-39.2% | -$30.57M-26.7% | -$25.95M— | -$24.7M— | -$24.51M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Carlsmed, Inc. Common Stock's revenue?
- Carlsmed, Inc. Common Stock (CARL) generated $56.4M in revenue over the trailing twelve months, up 74.9% year over year.
- Is Carlsmed, Inc. Common Stock profitable?
- Carlsmed, Inc. Common Stock is not currently profitable: it reported a net loss of $32.6M over the trailing twelve months, a -57.8% net margin.
- What are Carlsmed, Inc. Common Stock's profit margins?
- Gross margin is 75.9% and operating margin is -60.5%, with a -57.8% net margin.
- What is Carlsmed, Inc. Common Stock's earnings per share?
- Carlsmed, Inc. Common Stock's diluted EPS over the trailing twelve months is $-3.66.
- Where does Carlsmed, Inc. Common Stock's income statement data come from?
- Every line is extracted from Carlsmed, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
